Indian pharma stocks set for worst day in 2 years on Trump tariff woes

Laurus Labs

14/02/2025 09:17

** Indian pharma stocks  .NIPHARM  shed 3.1%, set for worst
day since late February 2022; benchmark Nifty 50  .NSEI  drops
0.8%
    ** API maker Laurus Labs  LAUL.NS  top pct loser on index
with 9.3% decline
    ** Sun Pharma  SUN.NS , India's top drugmaker by rev, Dr
Reddy's  REDY.NS  decline ~3% each, Cipla  CIPL.NS  falls 1%
    ** U.S. President Donald Trump is devising plans for
reciprocal tariffs on every country, however the imposition of
duties is likely to be delayed
    ** Analysts say India expected to be among worst hit by
reciprocal tariffs
        ** Drop in pharma stocks shows investors are extremely
jittery over uncertainties around quantum of tariffs that Trump
will impose on pharma imports from India, says Shrikant Akolkar,
analyst, Nuvama Institutional Equities
    ** Indian drugmakers derive significant chunk of revenue
from U.S.
    ** "Uncertainty over continued USAID funding is also
weighing on investors' sentiment," Akolkar says


 (Reporting by Kashish Tandon in Bengaluru)
 ((Kashish.tandon@thomsonreuters.com))